We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




PET Imaging More Effective than Angiogram for Determining Need for Coronary Stents or Bypass Surgery

By MedImaging International staff writers
Posted on 01 Dec 2022
Print article
Image: PET imaging technology used to map coronary blood flow and its outcomes in heart disease patients (Photo courtesy of UTHealth Houston)
Image: PET imaging technology used to map coronary blood flow and its outcomes in heart disease patients (Photo courtesy of UTHealth Houston)

Most forms of heart disease cause myocardial damage. Myocardial ischemia occurs when blood flow to the heart is reduced, preventing the heart muscle from receiving enough oxygen. When myocardial ischemia affects the deep, or subendocardial, layer of the left ventricular muscle, it is known as subendocardial ischemia. Subendocardial ischemia is commonly diagnosed in patients with cardiovascular disease, but it is not quantified by current imaging tools. The angiogram – an X-ray test that helps doctors evaluate blockages in the arterial system – shows how to do stents or bypass surgery, but not whether those procedures should be done at all.

Now, researchers at The University of Texas Health Science Center at Houston (Houston, TX, USA) have used positron emission tomography (PET) imaging technology to map coronary blood flow and its outcomes – namely, subendocardial ischemia – among patients with heart disease. The new method for determining whether patients with heart disease need coronary stents or bypass surgery is more effective than the angiogram, which is currently used, according to the researchers. The latest study confirmed the findings of their previous research by proving the PET threshold of severity at which stents and bypass surgery improve survival compared to medical treatment alone.

“The cumulative data reveals that all randomized trials of coronary stents and bypass surgery have failed to improve survival after revascularization due to profoundly flawed patient selection based on the angiogram,” said K. Lance Gould, MD, professor and the Martin Bucksbaum Distinguished University Chair in Heart Disease with McGovern Medical School at UTHealth Houston, who was first author on the study and led the team of researchers. “Thus, the coronary angiogram is not the gold standard for determining stents or bypass surgery, but rather, quantitative myocardial perfusion by PET is the gold standard.”

Related Links:
UTHealth Houston

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Software
UltraExtend NX
Under Table Shield
3 Section Double Pivot Under Table Shield
Compact C-Arm with FPD
Arcovis DRF-C R21

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.